Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam
· Delayed Price · Currency is VND 10,550
+150 (1.44%)
At close: Mar 6, 2026
HOSE:DBT Revenue
In the year 2025, Ben Tre Pharmaceutical JSC had annual revenue of 860.40B VND, down -0.92%. Ben Tre Pharmaceutical JSC had revenue of 279.00B in the quarter ending December 31, 2025, with 7.98% growth.
Revenue
860.40B
Revenue Growth
-0.92%
P/S Ratio
0.26
Revenue / Employee
1.26B
Employees
684
Market Cap
219.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 860.40B | -8.01B | -0.92% |
| Dec 31, 2024 | 868.41B | 56.80B | 7.00% |
| Dec 31, 2023 | 811.62B | 11.12B | 1.39% |
| Dec 31, 2019 | 800.50B | -9.41B | -1.16% |
| Dec 31, 2018 | 809.91B | 9.80B | 1.22% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vimedimex Medi-Pharma JSC | 1,172.99B |
| Mediplantex National Pharmaceutical JSC | 367.08B |
| Phong Phu Pharmaceutical JSC | 139.83B |
| Lamdong Pharmaceutical JSC | 243.91B |
| SPM Corporation | 253.96B |
| Cai Lay Veterinary Pharmaceutical JSC | 148.87B |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |